Suppr超能文献

第三次立体定向放射外科治疗复发性三叉神经痛的疗效和安全性:一项国际多中心研究。

Efficacy and safety of a third stereotactic radiosurgery for recurrent trigeminal neuralgia: an international, multicenter study.

机构信息

Vivian L. Smith Department of Neurosurgery at McGovern Medical School, Texas Institute for Restorative Neurotechnologies, UTHealth Houston, 6431 Fannin St, Houston, TX, 77030, USA.

Department of Neurological Surgery, Cleveland Clinic, Cleveland, OH, USA.

出版信息

Acta Neurochir (Wien). 2024 Oct 23;166(1):422. doi: 10.1007/s00701-024-06317-2.

Abstract

BACKGROUND AND OBJECTIVES

Trigeminal Neuralgia (TN) is a debilitating facial pain disorder, often necessitating surgical interventions when medication proves insufficient. Stereotactic Radiosurgery (SRS) is an established therapeutic option. Limited studies explored the feasibility of a third SRS procedure. Our study investigates the safety and efficacy of a third SRS procedure for recurrent TN.

METHODS

We performed a retrospective analysis across multiple centers using databases collected prospectively. Pain status was evaluated utilizing the BNI Pain Intensity Scales. The Kaplan-Meier method was employed to estimate the time to recurrence, with group comparisons conducted using log-rank tests. Associations were explored using Chi-square and logistic regression models.

RESULTS

Ten institutions contributed with a total of 35 patients. A third SRS revealed sustained effectiveness with a pain control rate of 82.7%. The median time to recurrence was 35.5 months. New sensory dysfunction following the third procedure occurred in 22% of patients who had preserved sensory function after the second procedure. When considering those who developed sensory dysfunction after the second procedure, 40% of the entire cohort was affected. There were no significant differences in pain recurrence intervals among the three procedures. A meta-analysis, combining data from previous studies, showed that 89.6% of patients achieved some degree of pain control after a third SRS, with 27.4% experiencing new sensory dysfunction and a median time to recurrence of 31.6 months.

CONCLUSION

Our study, the largest on the topic, affirms the sustained effectiveness of a third SRS for TN, providing comparable pain relief to initial procedures. Notably, an extended pain-free interval after the third SRS session was observed. Facial sensory dysfunction emerged as the primary side effect. Larger studies are warranted to explore correlations with demographics and treatment parameters for a comprehensive understanding of repeat SRS in managing recurrent TN.

摘要

背景与目的

三叉神经痛(TN)是一种使人虚弱的面部疼痛疾病,通常在药物治疗无效时需要手术干预。立体定向放射外科(SRS)是一种成熟的治疗选择。有限的研究探讨了第三次 SRS 治疗的可行性。我们的研究旨在调查第三次 SRS 治疗复发性 TN 的安全性和有效性。

方法

我们通过前瞻性收集数据库,在多个中心进行了回顾性分析。使用 BNI 疼痛强度量表评估疼痛状况。采用 Kaplan-Meier 方法估计复发时间,并使用对数秩检验比较组间差异。使用卡方和逻辑回归模型探索相关性。

结果

共有 10 个机构参与,共 35 例患者。第三次 SRS 显示出持续的有效性,疼痛控制率为 82.7%。复发的中位时间为 35.5 个月。在第二次 SRS 后保留感觉功能的患者中,有 22%的患者在第三次 SRS 后出现新的感觉功能障碍。考虑到第二次 SRS 后出现感觉功能障碍的患者,整个队列中有 40%的患者受到影响。三次手术的疼痛复发间隔无显著差异。一项荟萃分析,结合先前研究的数据,表明 89.6%的患者在第三次 SRS 后获得了某种程度的疼痛控制,其中 27.4%的患者出现新的感觉功能障碍,复发的中位时间为 31.6 个月。

结论

我们的研究是该领域最大的研究,证实了第三次 SRS 治疗 TN 的持续有效性,与初始手术相比提供了相当的疼痛缓解效果。值得注意的是,在第三次 SRS 治疗后观察到了更长的无疼痛间隔。面部感觉功能障碍是主要的副作用。需要更大规模的研究来探讨与人口统计学和治疗参数的相关性,以全面了解重复 SRS 在治疗复发性 TN 中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验